New Scientist

Personalised cancer vaccine expected to be approved next year

A bespoke vaccine that is tailored to target an individual's unique skin cancer reduced rates of recurrence or death in a late-stage trial, making an approval expected

By New Scientist

1 min read
Personalised cancer vaccine expected to be approved next year
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Science & R&D

Related Insights